Maher Mansur
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: United States Food and Drug Administration (2026); University of Alabama in Huntsville (2026)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Maher Mansur studies the structural dynamics of the SARS-CoV-2 spike protein and its impact on antibody activity. His work includes investigating how protein mutations can affect the binding and efficacy of therapeutic antibodies, such as bebtelovimab. Mansur utilizes molecular dynamics simulations to understand these interactions at a molecular level. His research network includes collaborators from the National Center for Toxicological Research, such as Marli S.P. Azevedo, Bridgett Knox, and Dongying Li, as well as Sachleen Singh from Arkansas State University. Mansur has one publication, contributing to the understanding of viral protein behavior and therapeutic interventions.
Metrics
- Publications: 1
Selected Publications
-
SARS-CoV-2 Spike Protein’s Structural Dynamics Affect the Activity of the Bebtelovimab Antibody (2026)
Collaboration Network
Top Collaborators
- SARS-CoV-2 Spike Protein’s Structural Dynamics Affect the Activity of the Bebtelovimab Antibody
- SARS-CoV-2 Spike Protein’s Structural Dynamics Affect the Activity of the Bebtelovimab Antibody
- SARS-CoV-2 Spike Protein’s Structural Dynamics Affect the Activity of the Bebtelovimab Antibody
- SARS-CoV-2 Spike Protein’s Structural Dynamics Affect the Activity of the Bebtelovimab Antibody
- SARS-CoV-2 Spike Protein’s Structural Dynamics Affect the Activity of the Bebtelovimab Antibody
- SARS-CoV-2 Spike Protein’s Structural Dynamics Affect the Activity of the Bebtelovimab Antibody
- SARS-CoV-2 Spike Protein’s Structural Dynamics Affect the Activity of the Bebtelovimab Antibody
- SARS-CoV-2 Spike Protein’s Structural Dynamics Affect the Activity of the Bebtelovimab Antibody
- SARS-CoV-2 Spike Protein’s Structural Dynamics Affect the Activity of the Bebtelovimab Antibody
- SARS-CoV-2 Spike Protein’s Structural Dynamics Affect the Activity of the Bebtelovimab Antibody
Similar Researchers
Based on overlapping research topics